Studies on Coagulation and Fibrinolysis in Pregnancy: With Special Reference to Cold Activation of Factor VII

References

• Arnesen H., Fagerhol M. K. α2-macroglobulin, α1-antitrypsin, and antithrombin III in plasma and serum during fibrinolytic therapy with urokinase. Scand J Clin Lab Invest 1972; 29: 259
   PubMed Web of Science ®Google Scholar
• Blix S. The proactivator of the fibrinolytic system in human plasma. Acta Med Scand 1962; 171: 83
   PubMedGoogle Scholar
• Bøyum A., Stormorken H., Lund-Riise A. Electronic platelet counting. Scand J Clin Lab Invest 1971; 28: 429
   PubMed Web of Science ®Google Scholar
• Donaldson V. H. Serum inhibitor of C'l-esterase in health and disease. J Lab Clin Med 1966; 68: 369
   PubMedGoogle Scholar
• Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thrombos Diathes Haemorrh 1965; 13: 516
   PubMedGoogle Scholar
• Ganrot P. O., Bjerre B. α1-antitrypsin and α2-macroglobulin concentration in serum during pregnancy. Acta Obstet Gynecol Scand 1967; 46: 126
   PubMed Web of Science ®Google Scholar
• Gigli I., Mason J. W., Colman R. W., Austen K. F. Interaction of kallikrein with the C'l esterase inhibitor (ClaINH). J Immunol 1968; 101: 814
   Google Scholar
• Gjønnæss H. Cold promoted activation of factor VII. I. Evidence for the existence of an activator. Thrombos Diathes Haemorrh 1972; 28: 155
   Google Scholar
• Gjønnæss H. Cold promoted activation of factor VII. II. Identification of the activator. Thrombos Diathes Haemorrh 1972; 28: 169
   Google Scholar
• Gjønnæss H. Cold promoted activation of factor VII. V. Relation to the fibrinolytic system. Thrombos Diathes Haemorrh 1973; 29: 143
   Google Scholar
• Gjønnæss H. Cold promoted activation of factor VII. Occurrence and relation to sex hormones and antifertility compounds. Gynecol Invest 1973; 4: 61
   Google Scholar
• Godal H. C., Theodor I. In vitro inhibition of streptokinase-induced proteolysis by Traylol and by Epsilon Amino Caproic Acid (EACA). Scand J Clin Lab Invest 1965; 17(Suppl. 84)199
   Google Scholar
• Harpel P. C. Human plasma α2-macroglobulin. An inhibitor of plasma kallikrein. J Exper Med 1970; 132: 329
   PubMed Web of Science ®Google Scholar
• Harpel P. C. C1 inactivator inhibition by plasmin. J Clin Invest 1970; 49: 568
   Google Scholar
• Hedner U., Åsted B. Studies on fibrinolytic inhibitors during pregnancy. Acta Obstet Gynecol Scand 1971; 50: 99
   PubMed Web of Science ®Google Scholar
• Jacobsen C. D. The use of N-ethyl-urethan in plasma plasminogen assay. Scand J Clin Lab Invest 1968; 21: 182
   PubMed Web of Science ®Google Scholar
• Jacobsen C. D. Proteolytic capacity in human plasma. I: Measurement of proteolytic activity in the presence of natural inhibitors and study of their inter-individual variations. Scand J Clin Lab Invest 1968; 21: 216
   PubMed Web of Science ®Google Scholar
• Kaplan A. P., Austen K. F. Digestion of activated Hageman factor by plasmin to form activators of prekallikrein. Fed Proc 1971; 30: 451
   Google Scholar
• Kasper C. K., Hoag M. S., Aggeler P. M. Blood clotting factors in pregnancy: Factor VIII concentrations in normal and AHF-deficient women. Obstet Gynecol 1964; 24: 242
   Google Scholar
• Laake K., Gjønnaess H., Fagerhol M. K. Components of the kallikrein-kinin system and the spontaneous cold activation of factor VII in human plasma. Acta Pharmacol Toxicol 1973; 33: 229
   Google Scholar
• Ludwig H. Thromboembolische Erkrankungen in der Schwangerschaft und während der Geburt. Z Geburthshilfe Perinatol 1972; 176: 169
   Google Scholar
• Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Int J Immunochem 1965; 2: 235
   PubMedGoogle Scholar
• Moe N. Thrombosis in normal pregnancy. T Norske Lægefor 1971; 91: 1727
   Google Scholar
• Nilsson I. M., Kullander S. Coagulation and fibrinolytic studies during pregnancy. Acta Obstet Gynecol Scand 1967; 46: 273
   PubMed Web of Science ®Google Scholar
• Owren P. A. Thrombotest. A new method for controlling anticoagulant therapy. Lancet 1959; 11: 754
   Google Scholar
• Owren P. A. The interrelationship between Normotest and Thrombotest. Farmakoterapi (Oslo) 1969; 25: 1
   Google Scholar
• Stamm H. Thromboembolische Komplikationen in der Schwangerschaft. Gynaecologia (Basel) 1967; 164: 137
   Google Scholar
• Tismer R., Egli H., Schander K. Untersuchungen über den Einfluss der Schwangerschaft auf aktivierende Faktoren der Blutgerinnung und die Thrombozyten. Z Geburtshilfe Perinatol 1972; 176: 183
   Google Scholar
• Wagner R. H., Brinkhous K. M., Penick G. D. Antihemophilic factor: Some problems in its study. Hemophilia and Hemophiloid States, K. M. Brinkhous. University of North Carolina Press. 1959; 3
   Google Scholar
• Wessler S. The role of hypercoagulability in venous and arterial thrombosis. Cardiovasc Clin 1971; 3: 1
   Google Scholar
• Ygge J. Changes in blood coagulation and fibrinolysis during the puerperium. Am J Obstet Gynecol 1969; 104: 2
   Google Scholar
• Åstedt B. On fibrinolysis. Acta Obstet Gynecol Scand 1972; 51(Suppl. 18)
   Google Scholar